CA2821779A1 - Monitoring volaemic condition in a human or animal subject - Google Patents
Monitoring volaemic condition in a human or animal subject Download PDFInfo
- Publication number
- CA2821779A1 CA2821779A1 CA2821779A CA2821779A CA2821779A1 CA 2821779 A1 CA2821779 A1 CA 2821779A1 CA 2821779 A CA2821779 A CA 2821779A CA 2821779 A CA2821779 A CA 2821779A CA 2821779 A1 CA2821779 A1 CA 2821779A1
- Authority
- CA
- Canada
- Prior art keywords
- haemodynamic
- variables
- subject
- data
- score
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 19
- 238000012544 monitoring process Methods 0.000 title claims description 24
- 230000001435 haemodynamic effect Effects 0.000 claims abstract description 175
- 238000012545 processing Methods 0.000 claims abstract description 79
- 238000000034 method Methods 0.000 claims abstract description 70
- 230000002159 abnormal effect Effects 0.000 claims abstract description 44
- 230000004087 circulation Effects 0.000 claims description 36
- 238000004590 computer program Methods 0.000 claims description 27
- 238000002560 therapeutic procedure Methods 0.000 claims description 19
- 230000009471 action Effects 0.000 claims description 11
- 230000002792 vascular Effects 0.000 claims description 9
- 230000007423 decrease Effects 0.000 claims description 8
- 230000035945 sensitivity Effects 0.000 claims description 8
- 230000035488 systolic blood pressure Effects 0.000 claims description 8
- 230000035487 diastolic blood pressure Effects 0.000 claims description 7
- 239000012636 effector Substances 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 238000004891 communication Methods 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 238000005096 rolling process Methods 0.000 claims description 4
- 230000035485 pulse pressure Effects 0.000 claims description 3
- 230000004872 arterial blood pressure Effects 0.000 claims description 2
- 230000004962 physiological condition Effects 0.000 claims description 2
- 230000000007 visual effect Effects 0.000 abstract description 5
- 206010021137 Hypovolaemia Diseases 0.000 description 19
- 239000012530 fluid Substances 0.000 description 15
- 208000032843 Hemorrhage Diseases 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 230000008859 change Effects 0.000 description 14
- 238000001356 surgical procedure Methods 0.000 description 8
- 238000013459 approach Methods 0.000 description 6
- 230000000740 bleeding effect Effects 0.000 description 5
- 230000000747 cardiac effect Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 206010002091 Anaesthesia Diseases 0.000 description 4
- 206010021138 Hypovolaemic shock Diseases 0.000 description 4
- 238000001949 anaesthesia Methods 0.000 description 4
- 230000037005 anaesthesia Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000036316 preload Effects 0.000 description 4
- 230000035939 shock Effects 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000001447 compensatory effect Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 230000036581 peripheral resistance Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 230000000213 tachycardiac effect Effects 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- YMHOBZXQZVXHBM-UHFFFAOYSA-N 2,5-dimethoxy-4-bromophenethylamine Chemical compound COC1=CC(CCN)=C(OC)C=C1Br YMHOBZXQZVXHBM-UHFFFAOYSA-N 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010016803 Fluid overload Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 206010058558 Hypoperfusion Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 241000545067 Venus Species 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- IYIKLHRQXLHMJQ-UHFFFAOYSA-N amiodarone Chemical compound CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1 IYIKLHRQXLHMJQ-UHFFFAOYSA-N 0.000 description 1
- 229960005260 amiodarone Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002283 elective surgery Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 210000004904 fingernail bed Anatomy 0.000 description 1
- 238000004868 gas analysis Methods 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000004855 vascular circulation Effects 0.000 description 1
- 230000006442 vascular tone Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Artificial Intelligence (AREA)
- Signal Processing (AREA)
- Psychiatry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Hematology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Vascular Medicine (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42401710P | 2010-12-16 | 2010-12-16 | |
| US61/424,017 | 2010-12-16 | ||
| PCT/AU2011/001612 WO2012079120A1 (en) | 2010-12-16 | 2011-12-15 | Monitoring volaemic condition in a human or animal subject |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2821779A1 true CA2821779A1 (en) | 2012-06-21 |
Family
ID=46243886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2821779A Abandoned CA2821779A1 (en) | 2010-12-16 | 2011-12-15 | Monitoring volaemic condition in a human or animal subject |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20140046153A1 (https=) |
| EP (1) | EP2651287A4 (https=) |
| JP (1) | JP2014500100A (https=) |
| CN (1) | CN103501692A (https=) |
| AU (1) | AU2011342370B2 (https=) |
| CA (1) | CA2821779A1 (https=) |
| IN (1) | IN2013MN01189A (https=) |
| WO (1) | WO2012079120A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI661384B (zh) * | 2015-02-06 | 2019-06-01 | 信立達科技有限公司 | 生理監控回饋系統及其運作方法 |
| JP6853790B2 (ja) * | 2015-05-13 | 2021-03-31 | マクエット カルディオプルモナリー ゲーエムベーハー | 臨床パラメータ計算シミュレーション監視システム |
| WO2018012246A1 (ja) * | 2016-07-12 | 2018-01-18 | 国立大学法人熊本大学 | 薬物動態解析方法、薬物動態解析装置及びプログラム |
| KR20190094214A (ko) * | 2016-12-15 | 2019-08-12 | 백스터 인터내셔널 인코포레이티드 | 감지된 정맥 파형으로부터 환자 파라미터들을 모니터링하고 결정하기 위한 시스템 및 방법 |
| WO2020150455A1 (en) * | 2019-01-17 | 2020-07-23 | Grant Hocking | A method to quantify the hemodynamic and vascular properties in vivo from arterial waveform measurements |
| CN110051336B (zh) * | 2019-04-24 | 2021-12-03 | 京东方科技集团股份有限公司 | 处理生理数据的方法、装置和存储介质 |
| CN111589065A (zh) * | 2020-06-02 | 2020-08-28 | 西安汇智医疗集团有限公司 | 基于多个监测单元协同的智能化呼吸训练系统 |
| DE102020117132A1 (de) * | 2020-06-30 | 2021-12-30 | Drägerwerk AG & Co. KGaA | Medizingerät zum Bestimmen eines Herzzeitvolumen-abhängigen Parameters |
| CN112450898A (zh) * | 2020-11-30 | 2021-03-09 | 刘宇峰 | 生命体征参数监测方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5103828A (en) * | 1988-07-14 | 1992-04-14 | Bomed Medical Manufacturing, Ltd. | System for therapeutic management of hemodynamic state of patient |
| US5584298A (en) * | 1993-10-25 | 1996-12-17 | Kabal; John | Noninvasive hemodynamic analyzer alterable to a continuous invasive hemodynamic monitor |
| US7831301B2 (en) * | 2001-03-16 | 2010-11-09 | Medtronic, Inc. | Heart failure monitor quicklook summary for patient management systems |
| US20050090753A1 (en) * | 2001-04-02 | 2005-04-28 | Daniel Goor | Device for determining hemodynamic state |
| US7937149B2 (en) * | 2003-12-03 | 2011-05-03 | Medtronic, Inc. | Method and apparatus for detecting change in physiologic parameters |
| US9757045B2 (en) * | 2004-01-27 | 2017-09-12 | Universiteit Gent | System and method for adaptive drug delivery |
| US7314451B2 (en) * | 2005-04-25 | 2008-01-01 | Earlysense Ltd. | Techniques for prediction and monitoring of clinical episodes |
| US20050209512A1 (en) * | 2004-03-16 | 2005-09-22 | Heruth Kenneth T | Detecting sleep |
| US8838215B2 (en) * | 2006-03-01 | 2014-09-16 | Angel Medical Systems, Inc. | Systems and methods of medical monitoring according to patient state |
| US8262579B2 (en) * | 2007-05-16 | 2012-09-11 | Massachusetts Institute Of Technology | System and method for prediction and detection of circulatory shock |
| ATE547044T1 (de) | 2007-10-11 | 2012-03-15 | Lidco Group Plc | Monitor zur hämodynamischen überwachung |
| EP3493216A1 (en) | 2007-11-13 | 2019-06-05 | Oridion Medical 1987 Ltd. | Medical system, apparatus and method |
| CN101959451B (zh) * | 2008-02-27 | 2014-06-25 | 皇家飞利浦电子股份有限公司 | 血液动力学监测器和警报器 |
| US8332146B2 (en) * | 2009-06-10 | 2012-12-11 | G-Tracking, Llc | Method and system for characterizing ride experiences |
| CN103561651B (zh) * | 2010-11-24 | 2017-03-22 | 数字制品有限责任公司 | 评估认知功能的系统和方法 |
-
2011
- 2011-12-15 IN IN1189MUN2013 patent/IN2013MN01189A/en unknown
- 2011-12-15 CA CA2821779A patent/CA2821779A1/en not_active Abandoned
- 2011-12-15 AU AU2011342370A patent/AU2011342370B2/en active Active
- 2011-12-15 EP EP11848199.3A patent/EP2651287A4/en not_active Withdrawn
- 2011-12-15 JP JP2013543469A patent/JP2014500100A/ja active Pending
- 2011-12-15 CN CN201180067584.9A patent/CN103501692A/zh active Pending
- 2011-12-15 US US13/994,866 patent/US20140046153A1/en not_active Abandoned
- 2011-12-15 WO PCT/AU2011/001612 patent/WO2012079120A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014500100A (ja) | 2014-01-09 |
| IN2013MN01189A (https=) | 2015-09-25 |
| EP2651287A4 (en) | 2014-06-18 |
| CN103501692A (zh) | 2014-01-08 |
| EP2651287A1 (en) | 2013-10-23 |
| AU2011342370B2 (en) | 2015-01-22 |
| US20140046153A1 (en) | 2014-02-13 |
| AU2011342370A1 (en) | 2012-12-06 |
| WO2012079120A1 (en) | 2012-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2011342370B2 (en) | Monitoring volaemic condition in a human or animal subject | |
| EP2442711B1 (en) | Determining haemodynamic performance | |
| Durairaj et al. | Fluid therapy in resuscitated sepsis: less is more | |
| US20150150516A1 (en) | Biological information processing system, wearable device, server system, method for controlling biological information processing system, and information storage medium | |
| EP4571776A1 (en) | Life information processing system and life information processing method | |
| WO2017001495A1 (en) | Optimal drug dosing based on current anesthesia practice | |
| WO2024163819A1 (en) | Systems and methods for measuring critical closing pressure and tissue perfusion pressure | |
| JP4892667B2 (ja) | 心疾患治療システム | |
| US20250268490A1 (en) | Assessment of fluid responsiveness | |
| WO2025117498A9 (en) | Continuous potassium measurement system and uses thereof | |
| Pothitakis et al. | Nursing role in monitoring during cardiopulmonary resuscitation and in the peri-arrest period: a review | |
| AU2014250646B2 (en) | Determining haemodynamic performance | |
| CN115251894A (zh) | 一种基于能量代谢的糖尿病人体评估系统 | |
| EP3776585B1 (en) | Customized healthcare management of a living subject | |
| US20240245345A1 (en) | Non-invasive detection and differentiation of sepsis | |
| US20260076581A1 (en) | Non-invasive blood pressure measurement | |
| Johnson et al. | Stroke volume optimization: utilization of the newest cardiac vital sign: considerations in recovery from cardiac surgery | |
| Onodugo et al. | Predictors of autonomic dysfunction among predialysis chronic kidney disease patients in Nigeria | |
| RU2194437C2 (ru) | Способ ранней диагностики гипертонической болезни | |
| WO2025227156A1 (en) | Systems and methods for measuring tissue perfusion pressure during extracorporeal life support | |
| Gavelli | Non-invasive hemodynamic monitoring techniques for detecting Preload responsiveness in critically ill patients | |
| Edul et al. | Cardiopulmonary monitoring in low-resource settings | |
| Prozhoga et al. | Indicator of stroke volume in estimating patient’s volemic status in the carotid endarterectomy | |
| Anyfanti et al. | [PP. 19.28] DETECTION OF RETINAL MICROVASCULAR ALTERATIONS IN RHEUMATOID ARTHRITIS PATIENTS WITHOUT CARDIOVASCULAR DISEASES | |
| Nehme et al. | [PP. 15.12] MEDICUS, A MOBILE-BASED, A PATIENT-CENTERED APPROACH TO THE TRACKING, PREDICTION, AND PREVENTION OF HYPERTENSION AND CARDIOVASCULAR CONDITIONS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20161201 |
|
| FZDE | Discontinued |
Effective date: 20191217 |